Mersana Therapeutics, Inc.: capex
| Value | {"amount": 1370000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2018-01-01 – 2018-12-31 |
| Status | current |
| Entity | Mersana Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/565d13ac-bb39-4c94-901f-284ed9bda98a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-19-001720Retrieved: 2026-08-19T14:14:28.455098+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001442836/capex/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/565d13ac-bb39-4c94-901f-284ed9bda98a
History
- no predecessors — first report